72 related articles for article (PubMed ID: 3065224)
1. [LH-RH analogues in metastatic breast cancer: first results].
Terzoli E; Izzo F; Nisticò C; Lucatelli S; Ranuzzi M
G Ital Oncol; 1988; 8(2):59-63. PubMed ID: 3065224
[No Abstract] [Full Text] [Related]
2. [Gonadotropin-releasing hormone analogues in the treatment of metastatic breast carcinoma].
Nesković-Konstantinović Z; Radulović S; Vuletić L
Srp Arh Celok Lek; 1993; 121(1-2):33-5. PubMed ID: 8202820
[TBL] [Abstract][Full Text] [Related]
3. Effective treatment of metastatic MDA-MB-435 human estrogen-independent breast carcinomas with a targeted cytotoxic analogue of luteinizing hormone-releasing hormone AN-207.
Chatzistamou L; Schally AV; Nagy A; Armatis P; Szepeshazi K; Halmos G
Clin Cancer Res; 2000 Oct; 6(10):4158-65. PubMed ID: 11051271
[TBL] [Abstract][Full Text] [Related]
4. Complete regression of MX-1 human breast carcinoma xenografts after targeted chemotherapy with a cytotoxic analog of luteinizing hormone-releasing hormone, AN-207.
Kahán Z; Nagy A; Schally AV; Halmos G; Arencibia JM; Groot K
Cancer; 1999 Jun; 85(12):2608-15. PubMed ID: 10375109
[TBL] [Abstract][Full Text] [Related]
5. [Pituitary gonadotropin releasing hormone (GnRH) and breast cancer].
Vargas Hernández VM; Moctezuma Espinosa J
Ginecol Obstet Mex; 1995 Dec; 63():493-6. PubMed ID: 8586292
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of premenopausal patients with advanced or recurrent breast cancer by chemical ablation].
Sun Q; Huang HY; Zhou YD; Mao F; Yang YQ; Xing Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Feb; 25(1):60-2. PubMed ID: 12905610
[TBL] [Abstract][Full Text] [Related]
7. Gonadotropin-releasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinoma.
Recchia F; Saggio G; Amiconi G; Di Blasio A; Cesta A; Candeloro G; Rea S
Cancer; 2006 Feb; 106(3):514-23. PubMed ID: 16388519
[TBL] [Abstract][Full Text] [Related]
8. [LH-RH analogs in mammary carcinoma: experimental aspects].
Scambia G; Benedetti Panici P; De Vincenzo R; Isola G; Mancuso S
Drugs Exp Clin Res; 1990; 16 Suppl():39-46. PubMed ID: 2081450
[No Abstract] [Full Text] [Related]
9. Potential use of analogs of luteinizing hormone-releasing hormones in the treatment of hormone-sensitive neoplasms.
Schally AV; Redding TW; Comaru-Schally AM
Cancer Treat Rep; 1984 Jan; 68(1):281-9. PubMed ID: 6362868
[TBL] [Abstract][Full Text] [Related]
10. Increased potency of four analogues of LH-releasing hormone in man.
Kastin AJ; Arimura A; Gonzalez-Barcena D; Coy DH; Miller MC; Nishi N; Lee L; Duron-Huerta H; Schalch DS; Schally AV
Int J Fertil; 1974; 19(4):202-6. PubMed ID: 4376535
[TBL] [Abstract][Full Text] [Related]
11. An implant releasing the gonadotropin hormone-releasing hormone agonist histrelin maintains medical castration for up to 30 months in metastatic prostate cancer.
Chertin B; Spitz IM; Lindenberg T; Algur N; Zer T; Kuzma P; Young AJ; Catane R; Farkas A
J Urol; 2000 Mar; 163(3):838-44. PubMed ID: 10687989
[TBL] [Abstract][Full Text] [Related]
12. Regulation of targeted chemotherapy with cytotoxic lutenizing hormone-releasing hormone analogue by epidermal growth factor.
Krebs LJ; Wang X; Pudavar HE; Bergey EJ; Schally AV; Nagy A; Prasad PN; Liebow C
Cancer Res; 2000 Aug; 60(15):4194-9. PubMed ID: 10945629
[TBL] [Abstract][Full Text] [Related]
13. Bombesin and epidermal growth factor potentiate the effect of cytotoxic LH-RH analog AN-152 in vitro.
Krebs LJ; Wang X; Nagy A; Schally AV; Prasad PN; Liebow C
Int J Oncol; 2002 Dec; 21(6):1325-9. PubMed ID: 12429984
[TBL] [Abstract][Full Text] [Related]
14. [A case of a premenopausal woman with advanced breast cancer treated with aromatization inhibition in combination with luteinizing hormone-releasing hormone agonist].
Hisamatsu K; Iwamori S; Minami K; Tanabe K; Ota K; Akiyama H
Gan To Kagaku Ryoho; 1997 Aug; 24(10):1327-30. PubMed ID: 9279354
[TBL] [Abstract][Full Text] [Related]
15. [Adjuvant chemotherapy of premenopausal breast cancer with LH-RH analogue for ovarian protection--a case report].
Asaga S; Ando J; Arai T; Fujii H
Gan To Kagaku Ryoho; 2005 Jul; 32(7):1069-72. PubMed ID: 16044976
[TBL] [Abstract][Full Text] [Related]
16. Luteinizing hormone releasing hormone analogues for contraception.
Nillius SJ
Clin Obstet Gynaecol; 1984 Dec; 11(3):551-72. PubMed ID: 6391776
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of hormone-dependent neoplasms (prostatic cancer, breast cancer). The place of LH-RH analogs].
Charron M
Soins; 1991 Sep; (552):61-4. PubMed ID: 1957225
[No Abstract] [Full Text] [Related]
18. [Long-term clinical study on TAP-144-SR, an LH-RH agonist depot formulation, in premenopausal patients with advanced or recurrent breast cancer. TAP-144-SR Breast Cancer Study Group].
Taguchi T; Koyama H; Yayoi K; Wada T; Takatsuka Y; Sonoo H; Morimoto K; Tominaga T; Abe R; Enomoto K
Gan To Kagaku Ryoho; 1995 Mar; 22(4):495-508. PubMed ID: 7887641
[TBL] [Abstract][Full Text] [Related]
19. [Pretreatment with chlormadinone acetate in prostate cancer patients treated with a luteinizing hormone-releasing hormone analogue].
Yamamoto A; Sumiyoshi Y; Miyake N; Yokozeki H; Kanayama H; Kagawa S
Hinyokika Kiyo; 1998 Aug; 44(8):557-63. PubMed ID: 9783191
[TBL] [Abstract][Full Text] [Related]
20. [The use of GnRH analogues in early and advanced breast carcinomas].
Ségura C; Avenin D; Gligorov J; Selle F; Estéso A; Beerblock K; Emile G; Do Huyen N; Lotz JP
Gynecol Obstet Fertil; 2005 Nov; 33(11):914-9. PubMed ID: 16246613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]